G-III服装集团 GIII 深 沪
已收盘 02-06 16:00:00 美东时间
30.51
+0.320
+1.06%
华盛通- 最 高30.78
- 今 开30.20
- 成交量 35.92万股
- 最 低 30.03
- 昨 收 30.19
- 总市值 12.87亿
- 52周最高 34.73
- 市盈率 静 7.27
- 换手率 0.85%
- 52周最低 20.23
- 委 比 88.12%
- 总股本 4218.93万
- 历史最高 73.83
- 量 比 0.77
- 振 幅 2.48%
- 历史最低 2.86
- 每 手 1
- 风险率 2.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多French Connection Group And G-III Apparel Group Announce Licensing Agreement For The North American Market, Effective February 1, 2026
French Connection Group (FCG) today announces a long-term partnership with G-III Apparel Group (G-III), a global expert in fashion, to develop and distribute men's and women's apparel and selected accessory products
01-27 02:03
What went wrong at Saks Global and what about the competition?
It's only mid-January, but investors have already witnessed what is likely to be one of the most notable bankruptcies of 2026. Saks Global, the luxury retailer behind brands like Saks Fifth Avenue, Ne...
01-15 19:39
Saks Global files for Chapter 11 bankruptcy, secures $1.75B financing commitment
Saks Global Enterprises has filed for Chapter 11 bankruptcy protection, barely a year after its $2.7B takeover of Neiman Marcus saddled it with a substantial debt load, marking one of the largest reta...
01-14 18:06
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
G-III Apparel Flags Tariff Risks But Still Raises Profit Outlook
G-III Apparel shares jumped after a profit beat, new dividend and higher earnings outlook offset weaker sales and margin pressure.
2025-12-10 00:43
G-III Apparel Group Initiates First Dividend Program
G-III Apparel Group ( ($GIII) ) has shared an update. On December 4, 2025, G-II...
2025-12-09 20:59
G-III Declares An Initial Quarterly Cash Dividend Of $0.10 Per Share
G-III announced today that its Board of Directors has approved a new quarterly dividend program to evolve its strategic use of capital. The Board of Directors declared an initial quarterly cash dividend of $0.10 per
2025-12-09 20:12
Earnings Scheduled For December 9, 2025
Companies Reporting Before The Bell • TH International (NASDAQ:THCH) is likely ...
2025-12-09 19:11
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
